Early research (Phase 1)Study completedNCT02710500What this trial is testingRAAVrh74.MHCK7.DYSF.DV for Treatment of DysferlinopathiesWho this might be right forDysferlinopathy Sarepta Therapeutics, Inc. 2
Large-scale testing (Phase 3)Study completedNCT00527228What this trial is testingDeflazacort in DysferlinopathiesWho this might be right forLGMD2BMiyoshi MyopathyDysferlinopathy Ludwig-Maximilians - University of Munich 25
Not applicableUnknownNCT01676077What this trial is testingClinical Outcome Study for DysferlinopathyWho this might be right forDysferlinopathyLGMD2B Now Classified as LGMDR2Miyoshi Myopathy Newcastle-upon-Tyne Hospitals NHS Trust 200
Not applicableStudy completedNCT06507215What this trial is testingDysferlinopathy Protein in Peripheral Blood Monocytes.Who this might be right forMuscular DystrophiesLimb-Girdle Muscular Dystrophy Type 2BMiyoshi Myopathy+1 more Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 149
Not applicableWithdrawnNCT01459302What this trial is testingGenetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular DisordersWho this might be right forAmyotrophic Lateral SclerosisFrontotemporal DementiaPLS+7 more University of Massachusetts, Worcester
Not applicableEnrolling By InvitationNCT04824040What this trial is testingClinical, Immunological, Morphological and Genetic Characteristics of Patients With Dysferlinopathy (LGMD R2) in the RFWho this might be right forDysferlinopathyMiyoshi MyopathyLGMDR2+1 more Artgen Biotech 100
Not applicableStudy completedNCT00893334What this trial is testingEvaluation of Limb-Girdle Muscular DystrophyWho this might be right forBecker Muscular DystrophyLimb-Girdle Muscular Dystrophy, Type 2A (Calpain-3 Deficiency)Limb-Girdle Muscular Dystrophy, Type 2B (Miyoshi Myopathy, Dysferlin Deficiency)+1 more Cooperative International Neuromuscular Research Group 60